| LDR | | 00000nmm u2200205 4500 |
| 001 | | 000000330150 |
| 005 | | 20241024160529 |
| 008 | | 181129s2018 ||| | | | eng d |
| 020 | |
▼a 9780438035997 |
| 035 | |
▼a (MiAaPQ)AAI10748306 |
| 035 | |
▼a (MiAaPQ)upenngdas:13126 |
| 040 | |
▼a MiAaPQ
▼c MiAaPQ
▼d 248032 |
| 049 | 1 |
▼f DP |
| 082 | 0 |
▼a 615 |
| 100 | 1 |
▼a Clark, Elisia. |
| 245 | 10 |
▼a Investigating Molecular Mechanisms Underlying Mild Phenotype in Friedreich Ataxia Patients with G130V Missense Mutation. |
| 260 | |
▼a [S.l.] :
▼b University of Pennsylvania.,
▼c 2018 |
| 260 | 1 |
▼a Ann Arbor :
▼b ProQuest Dissertations & Theses,
▼c 2018 |
| 300 | |
▼a 100 p. |
| 500 | |
▼a Source: Dissertation Abstracts International, Volume: 79-10(E), Section: B. |
| 500 | |
▼a Advisers: David Lynch |
| 502 | 1 |
▼a Thesis (Ph.D.)--University of Pennsylvania, 2018. |
| 520 | |
▼a Friedreich's Ataxia (FRDA) is an incurable neurodegenerative disease caused by mutations in the frataxin (FXN) gene, resulting in decreased expression of the mitochondrial protein FXN. 2-3% of FRDA patients carry a GAA expansion on one FXN allel |
| 590 | |
▼a School code: 0175. |
| 650 | 4 |
▼a Pharmacology. |
| 650 | 4 |
▼a Neurosciences. |
| 650 | 4 |
▼a Molecular biology. |
| 690 | |
▼a 0419 |
| 690 | |
▼a 0317 |
| 690 | |
▼a 0307 |
| 710 | 20 |
▼a University of Pennsylvania.
▼b Pharmacology. |
| 773 | 0 |
▼t Dissertation Abstracts International
▼g 79-10B(E). |
| 773 | |
▼t Dissertation Abstract International |
| 790 | |
▼a 0175 |
| 791 | |
▼a Ph.D. |
| 792 | |
▼a 2018 |
| 793 | |
▼a English |
| 856 | 40 |
▼u http://www.riss.kr/pdu/ddodLink.do?id=T14996979
▼n KERIS |
| 980 | |
▼a 201812
▼f 2019 |
| 990 | |
▼a 관리자
▼b 관리자 |